104
Participants
Start Date
March 31, 1998
Primary Completion Date
April 30, 2003
Study Completion Date
June 30, 2010
rituximab
fludarabine phosphate
Memorial Sloan-Kettering Cancer Center, New York
New York Presbyterian Hospital - Cornell Campus, New York
Mount Sinai Medical Center, NY, New York
CCOP - North Shore University Hospital, Manhasset
North Shore University Hospital, Manhasset
CCOP - Syracuse Hematology-Oncology Associates of Central New York, P.C., Syracuse
State University of New York - Upstate Medical University, Syracuse
CCOP - Christiana Care Health Services, Wilmington
Marlene & Stewart Greenebaum Cancer Center, University of Maryland, Baltimore
Duke Comprehensive Cancer Center, Durham
CCOP - Mount Sinai Medical Center, Miami Beach
University of Tennessee, Memphis Cancer Center, Memphis
University of Iowa Hospitals and Clinics, Iowa City
University of Illinois at Chicago Health Sciences Center, Chicago
University of Chicago Cancer Research Center, Chicago
Barnes-Jewish Hospital, St Louis
Ellis Fischel Cancer Center - Columbia, Columbia
CCOP - Southern Nevada Cancer Research Foundation, Las Vegas
University of California San Diego Cancer Center, La Jolla
UCSF Cancer Center and Cancer Research Institute, San Francisco
Walter Reed Army Medical Center, Washington D.C.
Massachusetts General Hospital Cancer Center, Boston
Dana-Farber Cancer Institute, Boston
University of Massachusetts Memorial Medical Center, Worcester
University of Nebraska Medical Center, Omaha
Norris Cotton Cancer Center, Lebanon
Roswell Park Cancer Institute, Buffalo
Lineberger Comprehensive Cancer Center, UNC, Chapel Hill
CCOP - Southeast Cancer Control Consortium, Winston-Salem
Comprehensive Cancer Center of Wake Forest University Baptist Medical Center, Winston-Salem
Rhode Island Hospital, Providence
Medical University of South Carolina, Charleston
Vermont Cancer Center, Burlington
MBCCOP - Massey Cancer Center, Richmond
National Cancer Institute (NCI)
NIH
Alliance for Clinical Trials in Oncology
OTHER